I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Clinical activity of nivolumab in combination with eribulin..:
Kim, Se Hyun
;
Im, Seock-Ah
;
Suh, Koung Jin
...
European Journal of Cancer, Vol.195, p. 113386. , 2023
Link:
https://hdl.handle.net/10371/197564
RT Journal T1
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_197564&Exemplar=1&LAN=DE A1 Kim, Se Hyun A1 Im, Seock-Ah A1 Suh, Koung Jin A1 Lee, Kyung-Hun A1 Kim, Min Hwan A1 Sohn, Joohyuk A1 Park, Yeon Hee A1 Kim, Ji-Yeon A1 Jeong, Jae Ho A1 Lee, Kyoung Eun A1 Choi, In Sil A1 Park, Kyong Hwa A1 Kim, Hee-Jun A1 Cho, Eun Kyung A1 Park, So Yeon A1 Kim, Milim A1 Kim, Jee Hyun PB Pergamon Press Ltd. YR 2023 K1 OPEN-LABEL K1 LOCALLY RECURRENT K1 PEMBROLIZUMAB K1 CHEMOTHERAPY K1 CHOICE K1 Advanced breast cancer K1 Clinical trial K1 Eribulin K1 Immune checkpoint inhibitors K1 Luminal breast cancer K1 Metastatic breast cancer K1 Nivolumab JF European Journal of Cancer, Vol.195, p. 113386 LK http://dx.doi.org/https://hdl.handle.net/10371/197564 DO https://hdl.handle.net/10371/197564 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)